BDBM711320 ((6-(difluoromethoxy)-2-(2,2'- dimethyl-3'-((3- (morpholinomethyl)-1,7- naphthyridin-8-yl)amino)-[1,1'- biphenyl]-3-yl)benzo[d]oxazol-5- yl)methyl)-L-proline::US12187713, Example 176

SMILES Cc1c(Nc2nccc3cc(CN4CCOCC4)cnc23)cccc1-c1cccc(-c2nc3cc(CN4CCC[C@H]4C(=O)O)c(OC(F)F)cc3o2)c1C

InChI Key InChIKey=NKBXBNKDPWONST-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 711320   

TargetProgrammed cell death 1 ligand/protein 1(Human)
Betta Pharmaceuticals

US Patent
LigandPNGBDBM711320(((6-(difluoromethoxy)-2-(2,2'- dimethyl-3'-((3- (m...)
Affinity DataIC50: 0.900nMAssay Description:The assays were conducted in a standard black 384-well polystyrene plate with a final volume of 20 μL. Inhibitors were first serially diluted in DMSO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/19/2025
Entry Details
Go to US Patent